![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 28, 2016 9:34:06 AM
This is not good for AMBS shareholders..if it was a Spin Off of AMBS DX then the AMBS shareholders would get the same amount of shares in the AVDX subsidiary..If you believe and have patience, in the lympro and MS IP you need to buy AVDX shares if this proposed merger is finalized..Sorry people...Thanks for bringing this to our attention Jam and JP..It is an acquisition and not a spin off...imo
Amarantus Diagnostics, into Avant Diagnostics. Under the terms of the LOI, upon execution of definitive merger agreements, Avant shall issue to Amarantus 80 million shares of common stock of Avant Diagnostics, representing approximately 45% of Avant's post-merger common stock, and 10 million additional shares of common stock upon achievement of certain sales milestones. Amarantus shall have the right to appoint two directors to the Avant Board of Directors,
Reverse Triangular Merger
A reverse triangular merger (also called a reverse subsidiary merger) is an acquisition structure where one company acquires another company using a subsidiary of the acquiring company. In a reverse triangular merger, a merger subsidiary of the acquiring company merges with and into the target company, with the target company surviving the merger. The somewhat counterintuitive result is that the acquired company continues to exist as an entity, but as a wholly-owned subsidiary of the acquiring company. Thus, this structure produces the same result as if the acquiring company had purchased all shares of stock of the acquired company. The reverse triangular merger can be contrasted with the forward triangular merger in which the acquired company ceases to exist.
http://witnesseth.typepad.com/blog/reverse-triangular-merger.html
This is from an 8-K..
On January 19, 2016, Avant Diagnostics, Inc. (the "Company") issued a press release announcing it has entered into a non-binding Letter of Intent to merge into, Amarantus Diagnostics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc.
if this "to merge into" statement is accurate, then AMDX is not "spun out" after all
as AMDX is not up-listed, autonomous, self-trading, and is still under the roof of AMBS
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM